Overview

Detection of Plaque Inflammation by Positron Emission Tomography (PET)-Effects of Simvastatin on Plaque Inflammation

Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine whether FDG-PET is capable of detecting atherosclerotic plaque inflammation and monitoring the effects of statins on plaque inflammation. The usefulness of FDG-PET in risk stratification is also investigated.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Kurume University
Treatments:
Simvastatin
Criteria
Inclusion Criteria:

- Protocol 1: patients who had carotid atherosclerosis detected by carotid ultrasound.

- Protocol 2: patients who underwent FDG-PET for cancer screening and had vascular FDG
uptakes

Exclusion Criteria:

- Active inflammatory diseases

- Dyslipidemia under medications

- Uncontrolled diabetes mellitus, vasculitis, symptomatic coronary artery disease,
symptomatic cerebrovascular diseases

- Known systemic disorders such as hepatic, renal, hematopoietic, and malignant diseases